Detalhe da pesquisa
1.
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study.
Ann Hematol
; 102(8): 2127-2136, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335322
2.
Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies.
Haematologica
; 107(3): 715-720, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320790
3.
Risk Factors for Bacteremia After Endoscopic Procedures in Hospitalized Patients With a Focus on Neutropenia.
J Clin Gastroenterol
; 56(1): e58-e63, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33337641
4.
Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3-ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remission.
Eur J Haematol
; 106(1): 64-71, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949053
5.
Attenuated humoral immune response following anti-SARS-CoV-2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis.
Am J Hematol
; 96(12): E475-E478, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622495
6.
Single agent oral selinexor as a key to potential cure in refractory diffuse large B-cell lymphoma: case report and literature review.
Am J Blood Res
; 11(1): 111-117, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33796398
7.
The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.
Nat Commun
; 12(1): 5397, 2021 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518534
8.
Does gender matter in non-hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy.
Rambam Maimonides Med J
; 5(4): e0038, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25386354